2024 Q2 Form 10-Q Financial Statement

#000143774924026819 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q2
Revenue -$178.8K -$307.1K
YoY Change -41.77% -91.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $850.0K -$14.77M
YoY Change -105.76% -60.73%
Net Earnings / Revenue
Basic Earnings Per Share $0.12 -$2.14
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 6.893M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.707K $2.703K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $5.701M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $4.683M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$175.8M
YoY Change
Common Stock $6.893K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $850.0K -$14.77M
YoY Change -105.76% -60.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $63.00 -$639.00
YoY Change -109.86% -99.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $0.00
YoY Change
NET CHANGE
Cash From Operating Activities $63.00 -$639.00
Cash From Investing Activities
Cash From Financing Activities $0.00 $0.00
Net Change In Cash $63.00 -$639.00
YoY Change -109.86% -99.0%
FREE CASH FLOW
Cash From Operating Activities $63.00 -$639.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-105273 usd
CY2024Q2 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
-651 usd
CY2023Q2 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
96581 usd
svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
1609 usd
svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
264896 usd
CY2024Q2 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
9723 usd
CY2023Q2 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-10000 usd
us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
10000 usd
us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
0 usd
CY2024Q2 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
32311 usd
CY2023Q2 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
176336 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-2967765 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
398443 usd
CY2024Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-26124 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-25426 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-51399 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
us-gaap Cash Held In Foreign Currency Acquisition Cost
CashHeldInForeignCurrencyAcquisitionCost
2629 usd
CY2023 us-gaap Cash Held In Foreign Currency Acquisition Cost
CashHeldInForeignCurrencyAcquisitionCost
2629 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
131676 usd
svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
62001 usd
svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
322938 usd
CY2024Q2 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
25953 usd
CY2024Q2 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
208767 usd
svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-7.9225 pure
CY2023 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.031 pure
CY2019 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-0.0284 pure
svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2023 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2022 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2021 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2020 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0.0802 pure
CY2019 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
-0.0991 pure
svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-7.9225 pure
CY2023 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.1112 pure
CY2019 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-0.1275 pure
svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
-7.9225 pure
CY2023 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.031 pure
CY2019 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.028 pure
svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
8.1133 pure
CY2023 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0813 pure
CY2022 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
-0.2096 pure
CY2021 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0294 pure
CY2020 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0064 pure
CY2019 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0393 pure
svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2023 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2022 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2021 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2020 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2019 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
-0.0033 pure
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
8.1133 pure
CY2023 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0813 pure
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.2096 pure
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0294 pure
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0064 pure
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.036 pure
us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0 pure
CY2023 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.01 pure
CY2022 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.15 pure
CY2021 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.16 pure
CY2020 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.13 pure
CY2019 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.18 pure
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133789617 usd
CY2024Q2 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
5.577 pure
CY2024Q2 svvc Net Assets Percentage Of Net Assets
NetAssetsPercentageOfNetAssets
1 pure
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133967669 usd
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
6.93 pure
CY2023Q4 us-gaap Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets
NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
5.93 pure
CY2023Q4 svvc Net Assets Percentage Of Net Assets
NetAssetsPercentageOfNetAssets
1 pure
CY2011Q2 us-gaap Operations Commenced Date1
OperationsCommencedDate1
2011-04-18
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 usd
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-168195
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3008946
dei Entity Address Address Line1
EntityAddressAddressLine1
150 Almaden Boulevard, Suite 1250
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95113
dei City Area Code
CityAreaCode
408
dei Local Phone Number
LocalPhoneNumber
886-7096
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6893056
CY2024Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133789617 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133967669 usd
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5676686 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8733779 usd
CY2024Q2 us-gaap Cash Held In Foreign Currency
CashHeldInForeignCurrency
2707 usd
CY2023Q4 us-gaap Cash Held In Foreign Currency
CashHeldInForeignCurrency
2765 usd
CY2024Q2 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
9770 usd
CY2023Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
8161 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
12250 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
63649 usd
CY2024Q2 us-gaap Assets
Assets
5701413 usd
CY2023Q4 us-gaap Assets
Assets
8808354 usd
CY2024Q2 us-gaap Management Fee Payable
ManagementFeePayable
10000 usd
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
0 usd
CY2024Q2 us-gaap Incentive Fee Payable
IncentiveFeePayable
4216017 usd
CY2023Q4 us-gaap Incentive Fee Payable
IncentiveFeePayable
7183782 usd
CY2024Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
30558 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
13891 usd
CY2024Q2 svvc Accrued Consultation Fees
AccruedConsultationFees
42000 usd
CY2023Q4 svvc Accrued Consultation Fees
AccruedConsultationFees
43000 usd
CY2024Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
384918 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
307310 usd
CY2024Q2 us-gaap Liabilities
Liabilities
4683493 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7547983 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
1017920 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
6893 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6893 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176770722 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176770722 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175759695 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175517244 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
1017920 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2024Q2 us-gaap Shares Outstanding
SharesOutstanding
7016432
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
7016432
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123376
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123376
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.15
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2024Q2 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
29956 usd
CY2024Q2 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
25953 usd
CY2023Q2 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
146723 usd
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
59656 usd
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
339543 usd
CY2024Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
30219 usd
CY2023Q2 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
29001 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
59245 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
57504 usd
CY2024Q2 us-gaap Custody Fees
CustodyFees
592 usd
CY2023Q2 us-gaap Custody Fees
CustodyFees
4440 usd
us-gaap Custody Fees
CustodyFees
1635 usd
us-gaap Custody Fees
CustodyFees
6600 usd
CY2024Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
5949 usd
CY2023Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
12633 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
11353 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
20511 usd
CY2024Q2 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
8814 usd
CY2023Q2 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
8801 usd
us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
17627 usd
us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
17505 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
89289 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
96540 usd
us-gaap Professional Fees
ProfessionalFees
157104 usd
us-gaap Professional Fees
ProfessionalFees
162309 usd
CY2024Q2 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
21038 usd
CY2023Q2 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
85923 usd
us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
42075 usd
us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
100471 usd
CY2024Q2 us-gaap Trustee Fees
TrusteeFees
5554 usd
CY2023Q2 us-gaap Trustee Fees
TrusteeFees
3336 usd
us-gaap Trustee Fees
TrusteeFees
41667 usd
us-gaap Trustee Fees
TrusteeFees
22086 usd
CY2024Q2 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
27508 usd
CY2023Q2 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
29612 usd
svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
55017 usd
svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
58900 usd
CY2024Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
19804 usd
CY2023Q2 us-gaap Other Noninterest Expense
OtherNoninterestExpense
21770 usd
us-gaap Other Noninterest Expense
OtherNoninterestExpense
39617 usd
us-gaap Other Noninterest Expense
OtherNoninterestExpense
42701 usd
CY2024Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
234720 usd
CY2023Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
438779 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
484996 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
828130 usd
CY2023Q2 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
-0 usd
svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
3059656 usd
svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
-0 usd
CY2023Q2 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
438779 usd
svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
-2574660 usd
svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
828130 usd
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
-178811 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
-307103 usd
us-gaap Net Investment Income
NetInvestmentIncome
2636661 usd
us-gaap Net Investment Income
NetInvestmentIncome
-505192 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
16 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
16 usd
CY2024Q2 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
0 usd
CY2023Q2 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
16 usd
us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
0 usd
us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-7864981 usd
CY2024Q2 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
1028811 usd
CY2023Q2 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-14461224 usd
us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-2879112 usd
us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-11140362 usd
CY2024Q2 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
1028811 usd
CY2023Q2 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-14461208 usd
us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-2879112 usd
us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-19005343 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
850000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14768311 usd
us-gaap Net Income Loss
NetIncomeLoss
-242451 usd
us-gaap Net Income Loss
NetIncomeLoss
-19510535 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.83
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
850000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14768311 usd
us-gaap Net Income Loss
NetIncomeLoss
-242451 usd
us-gaap Net Income Loss
NetIncomeLoss
-19510535 usd
CY2024Q2 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
-0 usd
CY2023Q2 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
100000 usd
us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
-0 usd
us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
100000 usd
CY2024Q2 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
20000 usd
CY2023Q2 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
0 usd
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
120000 usd
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
498425 usd
CY2024Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-27867 usd
CY2023Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-387743 usd
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-57981 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-16863 usd
CY2024Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
62198 usd
CY2023Q2 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-76387 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
93275 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-149544 usd
CY2024Q2 us-gaap Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-0 usd
CY2023Q2 us-gaap Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-0 usd
us-gaap Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-0 usd
us-gaap Realized Gain Loss Investment And Derivative Operating Before Tax
RealizedGainLossInvestmentAndDerivativeOperatingBeforeTax
-7864995 usd
CY2024Q2 svvc Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction And Other Assets Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionAndOtherAssetsOperatingAfterTax
1028811 usd
CY2023Q2 svvc Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction And Other Assets Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionAndOtherAssetsOperatingAfterTax
-14461135 usd
svvc Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction And Other Assets Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionAndOtherAssetsOperatingAfterTax
-2879112 usd
svvc Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction And Other Assets Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionAndOtherAssetsOperatingAfterTax
-11140275 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-639 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-701 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
63 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-639 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-58 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-701 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2644 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3342 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2765 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3404 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2707 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2703 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2707 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2703 usd
CY2024Q2 us-gaap Net Investment Income
NetInvestmentIncome
-178811 usd
CY2023Q2 us-gaap Net Investment Income
NetInvestmentIncome
-307103 usd
us-gaap Net Investment Income
NetInvestmentIncome
2636661 usd
us-gaap Net Investment Income
NetInvestmentIncome
-505192 usd
CY2024Q2 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
0 usd
CY2023Q2 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
16 usd
us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
0 usd
us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-7864981 usd
CY2024Q2 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
1028811 usd
CY2023Q2 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-14461224 usd
us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-2879112 usd
us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-11140362 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
850000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14768311 usd
us-gaap Net Income Loss
NetIncomeLoss
-242451 usd
us-gaap Net Income Loss
NetIncomeLoss
-19510535 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
850000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-14768311 usd
us-gaap Net Income Loss
NetIncomeLoss
-242451 usd
us-gaap Net Income Loss
NetIncomeLoss
-19510535 usd
CY2024Q1 us-gaap Assets Net
AssetsNet
167920 usd
CY2023Q1 us-gaap Assets Net
AssetsNet
25867367 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
1017920 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
11099056 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
1017920 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
11099056 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6893056
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.75
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.82
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.7
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.69
svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.38
CY2023 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.16
CY2022 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
-1.81
CY2021 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.44
CY2020 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.09
CY2019 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.9
svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2023 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2022 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2021 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2020 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2019 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
-0.08
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.38
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-1.81
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.44
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.09
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.82
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.41
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-4.42
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-7.5
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.51
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-2.3
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-12.15
svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2023 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2022 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2021 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2020 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
-1.13
CY2019 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
2.34
svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-0.41
CY2023 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-4.42
CY2022 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-7.5
CY2021 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-1.51
CY2020 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-3.43
CY2019 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-9.81
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.03
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-4.26
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-9.31
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.07
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-3.34
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-8.99
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2019 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2023 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2022 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2021 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2020 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0.46
CY2019 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2024Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.15
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.75
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.82
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.7
CY2024Q2 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.07
CY2023Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.3
CY2022Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.95
CY2021Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
4.01
CY2020Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
4.47
CY2019Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
6.43
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1667 pure
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.9595 pure
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.6771 pure
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0722 pure
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1627 pure
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.3368 pure
us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.7667 pure
CY2023 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.6842 pure
CY2022 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.7631 pure
CY2021 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.1029 pure
CY2020 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.3048 pure
CY2019 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.4259 pure
CY2024Q2 us-gaap Assets Net
AssetsNet
1000000 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1300000 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30600000 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
94800000 usd
CY2020Q4 us-gaap Assets Net
AssetsNet
102100000 usd
CY2019Q4 us-gaap Assets Net
AssetsNet
127100000 usd
svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
1.4924 pure
CY2023 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.1191 pure
CY2022 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.031 pure
CY2019 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.028 pure
svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-1.3016 pure
CY2023 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-0.1099 pure
CY2022 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-0.2096 pure
CY2021 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.0294 pure
CY2020 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.0064 pure
CY2019 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.036 pure
CY2019 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0564 pure
CY2024Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
5676686 usd
CY2024Q2 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
-4658766 usd
CY2024Q2 us-gaap Assets Net
AssetsNet
1017920 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8733779 usd
CY2023Q4 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
-7473408 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>USE OF ESTIMATES.</b> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CONCENTRATION OF CREDIT RISK. </b>The Company places its cash and cash equivalents with financial institutions and, at times, cash held in checking accounts <em style="font: inherit;"> may </em>exceed the Federal Deposit Insurance Corporation insured limit.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q2 svvc Deferred Compensation Arrangement Percent Of Compensation Deferred
DeferredCompensationArrangementPercentOfCompensationDeferred
0.50 pure
CY2024Q2 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
164724 usd
CY2024Q2 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
128277655 usd
CY2024Q2 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-128112931 usd
CY2024Q2 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
133789617 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698 pure
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3465923 usd
CY2024Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
9161034 usd
CY2024Q2 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
35040442 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47667399 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47667399 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2024Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12387144 usd
CY2023 svvc Operating Loss Carryforwards Period
OperatingLossCarryforwardsPeriod
P5Y
us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
0 usd
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
120000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
svvc-20240630_cal.xml Edgar Link unprocessable
0001437749-24-026819-index-headers.html Edgar Link pending
0001437749-24-026819-index.html Edgar Link pending
0001437749-24-026819.txt Edgar Link pending
0001437749-24-026819-xbrl.zip Edgar Link pending
ex_692224.htm Edgar Link pending
ex_692225.htm Edgar Link pending
ex_692226.htm Edgar Link pending
ex_711384.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
i46.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sccv20240630d_10q.htm Edgar Link pending
Show.js Edgar Link pending
sig01.jpg Edgar Link pending
svvc-20240630.xsd Edgar Link pending
svvc-20240630_def.xml Edgar Link unprocessable
svvc-20240630_lab.xml Edgar Link unprocessable
svvc-20240630_pre.xml Edgar Link unprocessable
sccv20240630d_10q_htm.xml Edgar Link completed